2m 2m 2m 2m 2m 2m 2m
LIPOCINE (LPCN)
NASDAQ
$2.66+$0.13 (+4.94%)
Price as of Jun 23, 2026 7:59 PM EDT- $18.9MMarket Cap
- -20.94%1-Year Change
- BiotechnologyIndustry
LIPOCINE (LPCN)
$2.66+$0.13 (+4.94%)
LPCN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.53 | ||
Change | +$0.24 (+10.48%) | ||
Open | $2.24 | ||
High | $2.67 | ||
Low | $2.24 | ||
Previous Close | $2.29 | ||
Volume | 207,877 | ||
30-Day Average Volume | 123,369 | ||
1-Week Change | 10.00% | ||
1-Month Change | 11.95% | ||
1-Year Change | -20.94% | ||
3-Year Change | -47.94% | ||
5-Year Change | -89.06% | ||
Fundamentals | |||
Shares Outstanding | 8.2M | ||
Total Assets | $25.4M | ||
Market Cap | $18.9M | ||
Enterprise Value | $13.9M | ||
Period: QTR TTM FY | |||
Revenue | $119,397.00 | ||
Net Income | -$3.7M | ||
Free Cash Flow | -$2.3M | ||
EBIT | -$3.7M | ||
EBITDA | -$3.7M | ||
Net Working Capital | $22.7M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 116 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 17 | ||
Last Split Date | 05/12/2023 | ||
Earnings & Revenue